These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

678 related articles for article (PubMed ID: 28888762)

  • 1. Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial.
    Borges NA; Carmo FL; Stockler-Pinto MB; de Brito JS; Dolenga CJ; Ferreira DC; Nakao LS; Rosado A; Fouque D; Mafra D
    J Ren Nutr; 2018 Jan; 28(1):28-36. PubMed ID: 28888762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does Low-Protein Diet Influence the Uremic Toxin Serum Levels From the Gut Microbiota in Nondialysis Chronic Kidney Disease Patients?
    Black AP; Anjos JS; Cardozo L; Carmo FL; Dolenga CJ; Nakao LS; de Carvalho Ferreira D; Rosado A; Carraro Eduardo JC; Mafra D
    J Ren Nutr; 2018 May; 28(3):208-214. PubMed ID: 29439931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.
    Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D
    Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Sevelamer on Serum Levels of Gut-Derived Uremic Toxins: Results from In Vitro Experiments and A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial.
    Bennis Y; Cluet Y; Titeca-Beauport D; El Esper N; Ureña P; Bodeau S; Combe C; Dussol B; Fouque D; Choukroun G; Liabeuf S
    Toxins (Basel); 2019 May; 11(5):. PubMed ID: 31109001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synbiotic meal decreases uremic toxins in hemodialysis individuals: A placebo-controlled trial.
    Lopes RCSO; Theodoro JMV; da Silva BP; Queiroz VAV; de Castro Moreira ME; Mantovani HC; Hermsdorff HH; Martino HSD
    Food Res Int; 2019 Feb; 116():241-248. PubMed ID: 30716942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of probiotic therapy on cardio-metabolic parameters and autonomic modulation in hypertensive women: a randomized, triple-blind, placebo-controlled trial.
    Romão da Silva LF; de Oliveira Y; de Souza EL; de Luna Freire MO; Braga VA; Magnani M; de Brito Alves JL
    Food Funct; 2020 Aug; 11(8):7152-7163. PubMed ID: 32756643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could resistant starch supplementation improve inflammatory and oxidative stress biomarkers and uremic toxins levels in hemodialysis patients? A pilot randomized controlled trial.
    Esgalhado M; Kemp JA; Azevedo R; Paiva BR; Stockler-Pinto MB; Dolenga CJ; Borges NA; Nakao LS; Mafra D
    Food Funct; 2018 Dec; 9(12):6508-6516. PubMed ID: 30468238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Probiotic Supplementation on Trimethylamine-N-Oxide Plasma Levels in Hemodialysis Patients: a Pilot Study.
    Borges NA; Stenvinkel P; Bergman P; Qureshi AR; Lindholm B; Moraes C; Stockler-Pinto MB; Mafra D
    Probiotics Antimicrob Proteins; 2019 Jun; 11(2):648-654. PubMed ID: 29651635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes.
    Asemi Z; Zare Z; Shakeri H; Sabihi SS; Esmaillzadeh A
    Ann Nutr Metab; 2013; 63(1-2):1-9. PubMed ID: 23899653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
    Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
    J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors of microinflammation in non-diabetic chronic kidney disease: a pilot study.
    Olivier V; Dunyach-Remy C; Corbeau P; Cristol JP; Sutra T; Burtey S; Lavigne JP; Moranne O
    BMC Nephrol; 2020 Apr; 21(1):141. PubMed ID: 32316931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Efficacy of Lactobacillus-Containing Probiotic Supplementation in Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Lim PS; Wang HF; Lee MC; Chiu LS; Wu MY; Chang WC; Wu TK
    J Ren Nutr; 2021 Mar; 31(2):189-198. PubMed ID: 32900583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial.
    Zamani B; Golkar HR; Farshbaf S; Emadi-Baygi M; Tajabadi-Ebrahimi M; Jafari P; Akhavan R; Taghizadeh M; Memarzadeh MR; Asemi Z
    Int J Rheum Dis; 2016 Sep; 19(9):869-79. PubMed ID: 27135916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal microbiota in pediatric patients with end stage renal disease: a Midwest Pediatric Nephrology Consortium study.
    Crespo-Salgado J; Vehaskari VM; Stewart T; Ferris M; Zhang Q; Wang G; Blanchard EE; Taylor CM; Kallash M; Greenbaum LA; Aviles DH
    Microbiome; 2016 Sep; 4(1):50. PubMed ID: 27640125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of sucroferric oxyhydroxide on gastrointestinal microbiome and uremic toxins in patients with chronic kidney disease undergoing hemodialysis.
    Iguchi A; Yamamoto S; Oda A; Tanaka K; Kazama JJ; Saeki T; Yamazaki H; Ishioka K; Suzutani T; Narita I
    Clin Exp Nephrol; 2020 Aug; 24(8):725-733. PubMed ID: 32285213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of Synbiotic Treatment on the Levels of Gut-Derived Uremic Toxins, Inflammation, and Gut Microbiome of Chronic Kidney Disease Patients-A Randomized Trial.
    Mitrović M; Stanković-Popović V; Tolinački M; Golić N; Soković Bajić S; Veljović K; Nastasijević B; Soldatović I; Svorcan P; Dimković N
    J Ren Nutr; 2023 Mar; 33(2):278-288. PubMed ID: 35995418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Synbiotics and Probiotics Supplementation on Serum Levels of Endotoxin, Heat Shock Protein 70 Antibodies and Inflammatory Markers in Hemodialysis Patients: a Randomized Double-Blinded Controlled Trial.
    Haghighat N; Mohammadshahi M; Shayanpour S; Haghighizadeh MH
    Probiotics Antimicrob Proteins; 2020 Mar; 12(1):144-151. PubMed ID: 30617950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study.
    Tonucci LB; Olbrich Dos Santos KM; Licursi de Oliveira L; Rocha Ribeiro SM; Duarte Martino HS
    Clin Nutr; 2017 Feb; 36(1):85-92. PubMed ID: 26732026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.
    Spaiser SJ; Culpepper T; Nieves C; Ukhanova M; Mai V; Percival SS; Christman MC; Langkamp-Henken B
    J Am Coll Nutr; 2015; 34(6):459-69. PubMed ID: 25909149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.